Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Rang in aandelen #38794
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Aandeelprijs
$0.02
Laatst gesynchroniseerd: 2026-08-13
Marktkapitalisatie
$801.34K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-18.70%
Land
US
Handel Agentix Corp. (AGTX)

Categorie

Koersgeschiedenis voor Agentix Corp. (AGTX)
Hoogste slotkoers: $0.02 op 2026-08-01

Laagste slotkoers: $13.07 op 2015-08-01
Koersgeschiedenis van Agentix Corp. van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -6.56%
2025 -78.30%
2024 515.58%
2023 -72.91%
2022 -82.45%
2021 61.22%
2020 -98.30%
2019 128.57%
2018 -65.57%
2017 13.66%
2016 21.09%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$507.29 29.97%
US
$848.63 30.07%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE